Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc

<< Previous

Bullboard Posts

Next >>

Post by shalomera2020on Dec 22, 2020 11:49am

182 Views

Post# 32160998

Mental Health Treatments and Telemedicine

(Keeping mentally healthy is what many are looking for. If you came across with this opportunity would you grab it?) https://cutt.ly/GoodPotentialForMentalHealthTreatment

Some of these other companies, have Advanced digital telehealth platform to make mental healthcare more affordable and convenient. Many of these companies are conducting research that could completely revolutionize the mental health field as we know it.

This might feed your curiosity about mental health and share others who's been suffering with this problem. Check the disclaimer on profile.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing